Are you Dr. Derman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 66 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
500 W Fort St
111
Boise, ID 83702Phone+1 208-422-1000Fax+1 208-422-1319
Summary
- Dr. Olga Derman, MD is an oncologist in Boise, Idaho. She is currently licensed to practice medicine in Idaho, New Jersey, and New York. She is affiliated with Boise VA Medical Center and St. Luke's Boise Medical Center.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2004 - 2007- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2000 - 2003
Stony Brook University Health Sciences Center School of MedicineClass of 2000
Certifications & Licensure
ID State Medical License 2019 - 2025
NY State Medical License 2003 - 2024
NJ State Medical License 2003 - 2019- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Busulfan, Melphalan, and Bortezomib Before First-Line Stem Cell Transplant in Treating Patients With Multiple Myeloma Start of enrollment: 2012 Feb 01
- A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation Start of enrollment: 2013 Aug 12
- A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients Start of enrollment: 2013 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 106 citationsEarly assessment of cancer outcomes in New York City firefighters after the 9/11 attacks: an observational cohort study.Rachel Zeig-Owens, Mayris P. Webber, Charles B. Hall, Theresa Schwartz, Nadia Jaber
Lancet. 2011-09-03 - 15 citationsHispanic ethnicity is associated with younger age at presentation but worse survival in acute myeloid leukemia.Karine Darbinyan, Aditi Shastri, Anjali Budhathoki, Daniel Helbig, Rose Snyder
Blood Advances. 2017-11-14 - 120 citationsAxicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma inclu...Ahmed Abbasi, Stephen Peeke, Nishi Shah, Jennat Mustafa, Fariha Khatun
Journal of Hematology & Oncology. 2020-01-03
